Loading company…
Xinji Medical develops polymer heart-valve devices for treating valvular heart disease.
Shanghai Xin Jiyuan Innovation Era Life Science, known as Xinji Medical, develops and manufactures polymer heart-valve devices. Founded in 2024 and based in Shanghai, China, it is pursuing R&D, preclinical evaluation, and human clinical trials. In January 2025, the company raised Angel funding led by Pudong Capital. It generates revenue through early-stage R&D partnerships, prototype development, and technology collaborations.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in